Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 10—October 2007

Dispatch

Borrelia burgdorferi Infection and Cutaneous Lyme Disease, Mexico

Guadalupe Gordillo-Pérez*, Javier Torres*, Fortino Solórzano-Santos*, Sylvie de Martino†, Dan Lipsker†, Edmundo Velázquez*, Guillermo Ramon*, Muñoz Onofre*, and Benoit Jaulhac†
Author affiliations: *Instituto Mexicano del Seguro Social, Mexico City, Mexico; †Hôpitaux Universitaires, Strasbourg, France;

Main Article

Figure 1

Western Blot (WB) immunoglobulin G results from cutaneous cases. A) WB with serum from patient 1, showing erythema migrans (arrow). B) WB with serum from patient 4, showing lymphocytoma (arrow); a strong positive and a weak positive control were included.

Figure 1. Western Blot (WB) immunoglobulin G results from cutaneous cases. A) WB with serum from patient 1, showing erythema migrans (arrow). B) WB with serum from patient 4, showing lymphocytoma (arrow); a strong positive and a weak positive control were included.

Main Article

TOP